companydata.dkcompanydata.dk

EJLIFS BESLAGSMEDIE ApS: Financial statements 2022

CVR: 29772991

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

EJLIFS BESLAGSMEDIE ApS (CVR 29772991) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 170,379 and a net result of DKK -93,712 compared with DKK -36,576 the year before. That is a decrease of 43.2% compared with the year before. Equity in the 2022 report amounted to DKK 122,687. The solvency ratio was 28.9%. The company had 1 employee in the financial year.

Gross Profit
DKK 170,379
Profit/Loss
DKK -93,712
Equity
DKK 122,687
Total Assets
DKK 424,269
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-170K-94K123K1
2021-300K-37K216K-
2020676K445K64K308K-
2019603K320K-5K244K-
2018669K427K158K303K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on EJLIFS BESLAGSMEDIE ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

EJLIFS BESLAGSMEDIE ApS: The 2021 annual report is outJun 23, 2022

EJLIFS BESLAGSMEDIE ApS has published its annual report for 2021. Gross profit came to DKK 299,875, and the net result was DKK -36,576.

About EJLIFS BESLAGSMEDIE ApS

EJLIFS BESLAGSMEDIE ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2006. The company is registered under the industry Støtteaktiviteter i forbindelse med husdyravl. The company was previously named CLINICAL RESEARCH FOCUS ApS and VICH 8995 ApS. The management consists of Ejlif Schmidt-Petersen. The company is owned by Ejlif Schmidt-Petersen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 37,588 and a net result of DKK -105,303 compared with DKK -48,785 the year before. Equity in the 2025 report amounted to DKK -23,188.

Source: annual report 2025, Danish Business Authority